Navigation Links
Pain Reported by Nearly Half With Type 2 Diabetes

TUESDAY, Aug. 14 (HealthDay News) -- Nearly 50 percent of patients with type 2 diabetes say they have acute and chronic pain, and about one-quarter suffer from a wide range of symptoms, including nerve damage, fatigue and depression, a new study indicates.

As a result, specialized treatment, called palliative care, that focuses on relieving symptoms and improving quality of life should be a normal part of diabetes management, the researchers suggest.

"Adults living with type 2 diabetes are suffering from incredibly high rates of pain and non-pain symptoms, at levels similar to patients living with cancer," lead study author Dr. Rebecca Sudore, a staff physician at San Francisco VA Medical Center and associate professor of medicine at the University of California, San Francisco, said in a news release that was released jointly by the medical center, the university and Kaiser Permanente.

"Palliative care has already begun to be woven into the care provided to patients with cancer, heart failure and kidney failure," Sudore added. "Our results highlight the need to expand diabetes management to also include the palliative care model."

In conducting the study, researchers from the San Francisco VA Medical Center, the University of California, San Francisco and the Kaiser Permanente Division of Research in Oakland, Calif., examined more than 13,000 adults with type 2 diabetes, aged 30 to 75.

In addition to chronic pain, fatigue and depression, about one in four patients reported neuropathy, which is characterized by tingling or numbness in hands, legs or feet; problems sleeping; and physical or emotional disability, the study revealed. Researchers also found high rates of shortness of breath, nausea and constipation.

Although these symptoms occurred among patients of all ages, the researchers said they were more common toward the end of life.

"The field of diabetes has focused, and rightfully so, on decreasing patients' blood sugar, blood pressure and cholesterol levels in an attempt to prevent complications such as cardiovascular disease, kidney failure, amputations and blindness," Andrew Karter, senior research scientist at Kaiser, said in the joint news release.

"However, our observations provide an important wake-up call for clinicians to not wait until the latest stages of diabetes to focus on these patient-reported outcomes, but rather to consider early palliative care as part of usual chronic disease management," Karter said.

The study was published online Aug. 3 in the Journal of General Internal Medicine.

Nearly 26 million Americans -- or more than 8 percent of the U.S. population -- have diabetes, according to the U.S. Centers for Disease Control and Prevention. Most have the type 2 form of the disease, which is associated with obesity and a sedentary lifestyle. These people don't produce enough insulin or properly use insulin, a hormone needed to convert food into energy. Over time, the damage caused by type 2 diabetes can lead to serious illness and death.

More information

The U.S. National Library of Medicine has more about palliative care.

-- Mary Elizabeth Dallas

SOURCE: San Francisco VA Medical Center, University of California, San Francisco and Kaiser Permanente, news release, Aug. 7, 2012

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Survival rates for premature babies in high-level NICUs are better than previously reported
2. Vertebroplasty reportedly provides better pain relief and function
3. Pandemic H1N1 Flu Killed Far More Than Reported: Study
4. Reported increase in older adult fall deaths due to improved coding
5. On-the-job deaths steady in Michigan; Number of burn injuries underreported
6. Diagnostic yield of colonoscopy for melena after nondiagnostic upper endoscopy is lower than previously reported
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Clemson researcher awarded nearly $245,000 to study automation trust and dependence
9. GW School of Nursing receives nearly $1 million grant to diversify nursing workforce
10. Scripps Florida scientists awarded nearly $1.5 million to develop new approaches to treat cancer
11. Einstein receives nearly $5 million to study how Ebola causes infection
Post Your Comments:
Related Image:
Pain Reported by Nearly Half With Type 2 Diabetes
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: